Estrogen Receptor α/14-3-3 molecular glues as alternative treatment strategy for endocrine resistant breast cancer
Emira J. Visser(Institute of Chemistry and Chemical Technology), Luc Brunsveld(Eindhoven University of Technology), Onno C. Meijer(Loyola University Medical Center), Leonie S. Young(Unknown), B. Somsen(TropIQ Health Sciences), L Luzietti, Michelle R. Arkin(University of California, San Francisco), Susana N. Paul(Leiden University Medical Center), Maria Donaldson Collier(The Netherlands Cancer Institute), Simak Ali(The London College), Markella Konstantinidou(University of California, San Francisco), Joseph C. Siefert(The Netherlands Cancer Institute), Galen P. Miley(Eindhoven University of Technology), Johanna M. Virta(University of California, San Francisco), Peter J. Cossar(University of Dundee), Damir Varešlija(University College Dublin), Jari B. Berkhout(Leiden University Medical Center), Wilbert Zwart(Oncode Institute), Lakjaya Buluwela(Imperial College London), Christian Ottmann(Institute of Chemistry and Chemical Technology)
Cited by 5
Related Papers
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
|Cell|2014|2.5k
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
|Science|2013|2.5k
Long-Range Photoinduced Electron Transfer Through a DNA Helix
|Science|1993|951
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
|Science|2014|911
A microfluidic device for label-free, physical capture of circulating tumor cell clusters
|Nature Methods|2015|726